Home - Products - Others - Other Targets - Benin

Benin

CAS No. 22181-94-8

Benin( Butocin | Butocine )

Catalog No. M24003 CAS No. 22181-94-8

Benin is an effective cytostatic drug used for the treatment of generalized carcinoma of the breast.

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
1 mL x 10 mM in DMSO	542	In Stock
5MG	493	In Stock
10MG	678	In Stock
25MG	1007	In Stock
50MG	1321	In Stock
100MG	1776	In Stock
200MG	Get Quote	In Stock
500MG	Get Quote	In Stock
1G	Get Quote	In Stock

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Benin
Note

Research use only, not for human use.
Brief Description

Benin is an effective cytostatic drug used for the treatment of generalized carcinoma of the breast.
Description

Benin is an effective cytostatic drug used for the treatment of generalized carcinoma of the breast.(In Vitro):Benin is a cytostatic drug, but inactive in the standard plate incorporation method of Ames reversion test using four Salmonella typhimurium strains.
In Vitro

——
In Vivo

——
Synonyms

Butocin | Butocine
Pathway

Others
Target

Other Targets
Recptor

Others
Research Area

——
Indication

——

Chemical Information

CAS Number

22181-94-8
Formula Weight

337.4
Molecular Formula

C14H19N5O3S
Purity

>98% (HPLC)
Solubility

DMSO:10 mM
SMILES

CCOC(=O)CNC(=O)CCCCSC1=NC=NC2=C1NC=N2
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

1.J. Marhan. Mutagenicity of cytostatic drugs in a bacterial system. Folia Microbiologica October 1995, Volume 40, Issue 5, pp 462-466.

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Itaconic anhydride

Itaconic anhydride
Ac-Ile-Tyr-Gly-Glu-P...

p60c-src substrate II is an efficient pentapeptide substrate for the tyrosine kinase pp60c-src.
PACAP (1-38), human,...

PACAP (1-38), a novel neuropeptide isolated from the bovine hypothalamus is more active than vasoactive intestinal peptide (VIP) in stimulating adenylate cyclase (EC50=7 nM). PACAP 1-38 (10-9 M) increased substance P (SP), gastrin releasing peptide (GRP), and VIP release. PACAP 1-38 (10-8 M) inhibited gastrin secretion and stimulated somatostatin secretion and motility dose-dependently.

Sign In Join Free